Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.

Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.

Item
http://www.wikidata.org/entity/Q44508371
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysisCombination of cyclophosphamide, etoposide, carboplatin and dexamethasone as a salvage regimen for refractory multiple myeloma patients: a comparison with a historical control group.Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma.High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma.The treatment of the elderly multiple myeloma patients.Current trends in multiple myeloma management.Combination regimens using doxorubicin and pegylated liposomal doxorubicin prior to autologous transplantation in multiple myeloma.Clinical Features of Bone Complications and Prognostic Value of Bone Lesions Detected by X-ray Skeletal Survey in Previously Untreated Patients with Multiple Myeloma.Outcomes of primary refractory multiple myeloma and the impact of novel therapies.Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.Is there still place for VAD as primary treatment for patients with multiple myeloma who are candidates for high-dose therapy?
P2860

Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.

Item
http://www.wikidata.org/entity/Q44508371
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Prospective randomized compari ...... treatment in multiple myeloma.
@en
Prospective randomized compari ...... treatment in multiple myeloma.
@nl
type
label
Prospective randomized compari ...... treatment in multiple myeloma.
@en
Prospective randomized compari ...... treatment in multiple myeloma.
@nl
prefLabel
Prospective randomized compari ...... treatment in multiple myeloma.
@en
Prospective randomized compari ...... treatment in multiple myeloma.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Prospective randomized compari ...... treatment in multiple myeloma
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921